Prodotto aggiunto correttamente al carrello.

discount label
Substance P
Visualizzare in 3D

Biosynth logo

Substance P

Rif. 3D-PP47022

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Martedì 29 Ottobre 2024

Informazioni sul prodotto

Nome:
Substance P
Sinonimi:
  • H-RPKPQQFFGLM-NH2
Descrizione:

Peptide Substance P is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Substance P include the following: A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid Z Liu, M Welin, B Bragee , F Nyberg - Peptides, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978100002199 Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis Y Lee, Y Kawai, S Shiosaka , K Takami, H Kiyama - Brain Research, 1985 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0006899385900277 Highly selective agonists for substance P receptor subtypes. U Wormser, R Laufer, Y Hart, M Chorev , C Gilon - The EMBO , 1986 - embopress.orghttps://www.embopress.org/doi/abs/10.1002/j.1460-2075.1986.tb04571.x Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist U Gether , TE Johansen, RM Snider, JA Lowe III - Nature, 1993 - nature.comhttps://www.nature.com/articles/362345a0 Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels T Naito , H Itoh, M Takeyama - Biological and Pharmaceutical Bulletin, 2003 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bpb/26/8/26_8_1104/_article/-char/ja/ Therapeutic effects of neuropeptide substance P coupled with self-assembled peptide nanofibers on the progression of osteoarthritis in a rat model SJ Kim, JE Kim, SH Kim, SJ Kim, SJ Jeon, SH Kim - Biomaterials, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961215007917 Role of substance P and calcitonin gene-related peptide in the regulation of interleukin-8 and monocyte chemotactic protein-1 expression in human dental pulp SH Park, GYW Hsiao, GTJ Huang - International endodontic , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.0143-2885.2004.00782.x Substance p SE Leeman, EA Mroz - Life sciences, 1974 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0024320574900204 Substance P regulates the vasodilator activity of calcitonin gene-related peptide SD Brain , TJ Williams - Nature, 1988 - nature.comhttps://www.nature.com/articles/335073a0 Cleavage of substance P to an N-terminal tetrapeptide and a C-terminal heptapeptide by a post-proline cleaving enzyme from bovine brain S Blumberg, VI Teichberg, JL Charli , LB Hersh - Brain research, 1980 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0006899380908987 Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase RA Skidgel, S Engelbrecht, AR Johnson, EG Erdös - Peptides, 1984 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0196978184900202 Elevation of substance P-like peptides in the CSF of psychiatric patients. R Rimon, P Le Greves, F Nyberg, L Heikkila - Biological , 1984 - europepmc.orghttps://europepmc.org/article/med/6203562 Substance P: structure, function, and therapeutics P Datar, S Srivastava, E Coutinho - Current topics in , 2004 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ctmc/2004/00000004/00000001/art00009 Substance P receptor-mediated chemotaxis of human monocytes MR Ruff, SM Wahl, CB Pert - Peptides, 1985 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0196978185901421 Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P MM Chang, SE Leeman - Journal of Biological Chemistry, 1970 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818628601 The mast cell response to substance P: effects of neuraminidase, limulin, and some novel synthetic peptide antagonists JW Coleman, Q Huang, DR Stanworth - Peptides, 1986 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0196978186902081 Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides J Oehlke, D Lorenz, B Wiesner - Journal of Molecular , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmr.691 Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis J Chan, BR Smoller, SP Raychauduri, WY Jiang - Archives of , 1997 - Springerhttps://link.springer.com/article/10.1007/s004030050249 Selective localization of vasoactive intestinal peptide and substance P in human eosinophils J Aliakbari, SP Sreedharan, CW Turck - and biophysical research , 1987 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X87802930 Non-radioactive localization of substance P binding sites in rat brain and spinal cord using peptides labeled with 1.4-nm gold particles. G Segond von Banchet - of Histochemistry & , 1995 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/43.8.7542681 Substance P analogues function as bombesin receptor antagonists and inhibit small cell lung cancer clonal growth G Bepler, U Zeymer, S Mahmoud, G Fiskum - Peptides, 1988 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0196978188902045 Characterization of substance P (1-7) and (1-8) generating enzyme in human cerebrospinal fluid F Nyberg, P Le Greves, C Sundqvist - and biophysical research , 1984 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X84803605 Substance P: a polypeptide of possible physiological significance, especially within the nervous system F Lembeck, G Zetler - International Review of Neurobiology, 1962 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0074774208600227 Liver dipeptidyl aminopeptidase IV hydrolyzes substance P E Heymann, R Mentlein - FEBS letters, 1978 - core.ac.ukhttps://core.ac.uk/download/pdf/82412986.pdf Characterization of two substance P antisera E BRODIN, G NILSSON - Acta Physiologica , 1982 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1748-1716.1982.tb06951.x Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord DH Smullin, SR Skilling, AA Larson - Pain, 1990 - Elsevierhttps://www.sciencedirect.com/science/article/pii/030439599091095Z The effects of substance P on histamine and 5-hydroxytryptamine release in the rat CMS Fewtrell, JC Foreman, CC Jordan - The Journal of , 1982 - Wiley Online Libraryhttps://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/jphysiol.1982.sp014347 Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study C Weidner, M Klede, R Rukwied, G Lischetzki - Journal of Investigative , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15410760 Pharmacological properties of a potent and selective nonpeptide substance P antagonist. C Garret, A Carruette, V Fardin - Proceedings of the , 1991 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.88.22.10208 Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells AM Garland, EF Grady, DG Payan, SR Vigna - Biochemical , 1994 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/303/1/177/31215 Neuropeptide substance P and the immune response A Mashaghi , A Marmalidou, M Tehrani - Cellular and molecular , 2016 - Springerhttps://link.springer.com/article/10.1007/s00018-016-2293-z Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in pseudocapsules of uterine fibroids A Malvasi, A Tinelli , C Cavallotti, M Morroni, DA Tsin - Peptides, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978110005292 In vitro functional study of RP 67580, a new non-peptide substance P antagonist with different tissue preparations A Carruette, A Champion, P Goniot, D Cottez - , 1992 - academia.eduhttps://www.academia.edu/download/75194951/0143-4179_2892_2990373-520211125-667-1s68oj3.pdf

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

Peso molecolare:
1,347.66 g/mol
Formula:
C63H98N18O13S
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP47022 Substance P

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".